EOID

(redirected from Expert Opinion on Investigational Drugs)
AcronymDefinition
EOIDElectro-Optic Identification
EOIDExpert Opinion on Investigational Drugs (medical journal)
References in periodicals archive ?
In a 2010 peer-reviewed publication, "NX-1207: a novel investigational drug for the treatment of benign prostatic hyperplasia" in Expert Opinion on Investigational Drugs (2010 Feb;19(2):305-10), the author, Neal Shore MD FACS, Medical Director of the Carolina Urologic Research Center, Myrtle Beach, SC, wrote, "Regarding existing oral drug therapies, the use of NX-1207 would obviate daily and lifelong compliance issues as well as the ongoing concerns of polypharmacy facing the elderly and the attendant risk for drug--drug interactions.
Nymox Pharmaceutical Corporation (Nasdaq:NYMX) Hasbrouck Heights, N.J., has announced the publication of a new peer- reviewed paper in Expert Opinion on Investigational Drugs featuring NX-1207, the company's innovative treatment for benign prostatic hyperplasia (BPH).
Full browser ?